Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Dubé

Chistopher E. Dubé, Lexington, MA US

Patent application numberDescriptionPublished
20100000602Photovoltaic Cell with Efficient Finger and Tab Layout - A photovoltaic cell has a photosensitive substrate, a plurality of fingers in ohmic contact with the substrate, and a plurality of pads on the substrate. The plurality of pads effectively form a plurality of discontinuous busbars. Two of the fingers extend from a first pad of the plurality of pads. Specifically, a given one of the two fingers (“given finger”) may connect with a second pad of the plurality of pads. This given finger may have an inter-pad portion between the first and second pads. The cell further has a tab at least partially covering the inter-pad portion of the given finger.01-07-2010

Chistopher E. Dubé, Lexington, MA US

Patent application numberDescriptionPublished
20100000602Photovoltaic Cell with Efficient Finger and Tab Layout - A photovoltaic cell has a photosensitive substrate, a plurality of fingers in ohmic contact with the substrate, and a plurality of pads on the substrate. The plurality of pads effectively form a plurality of discontinuous busbars. Two of the fingers extend from a first pad of the plurality of pads. Specifically, a given one of the two fingers (“given finger”) may connect with a second pad of the plurality of pads. This given finger may have an inter-pad portion between the first and second pads. The cell further has a tab at least partially covering the inter-pad portion of the given finger.01-07-2010

Christopher E. Dubé, Lexington, MA US

Patent application numberDescriptionPublished
20110023952PHOTOVOLTAIC CELL WITH SEMICONDUCTOR FINGERS - A photovoltaic cell has a semiconductor substrate formed from semiconductor material doped by a first dopant type, and a doped region over at least a portion of the substrate. The doped region is doped by a second dopant type that is opposite to that of the first dopant type to form an emitter. Moreover, the doped region is doped to a region dopant level. In addition to the substrate and emitter, the cell also has a plurality of semiconductor fingers formed on the emitter, a plurality of busbars formed from a conductor and intersecting the plurality of semiconductor fingers, and a plurality of tabs soldered to the busbars. The fingers are doped by the second dopant type to have a second dopant level, which is greater than the region dopant level.02-03-2011

Christopher E. Dubé, Lexington, MA US

Patent application numberDescriptionPublished
20090159114Photovoltaic Panel and Cell with Fine Fingers and Method of Manufacture of the Same - A photovoltaic cell has a photosensitive substrate and a plurality of fingers in ohmic contact with the substrate. At least one of the fingers has an average width of less than about 95 microns. The cell also has a plurality of busbars in ohmic contact with the fingers. At least two of the busbars that are spaced less than about 38 millimeters apart intersect the at least one finger (i.e., the finger(s) having an average width of less than about 95 microns).06-25-2009
20110023952PHOTOVOLTAIC CELL WITH SEMICONDUCTOR FINGERS - A photovoltaic cell has a semiconductor substrate formed from semiconductor material doped by a first dopant type, and a doped region over at least a portion of the substrate. The doped region is doped by a second dopant type that is opposite to that of the first dopant type to form an emitter. Moreover, the doped region is doped to a region dopant level. In addition to the substrate and emitter, the cell also has a plurality of semiconductor fingers formed on the emitter, a plurality of busbars formed from a conductor and intersecting the plurality of semiconductor fingers, and a plurality of tabs soldered to the busbars. The fingers are doped by the second dopant type to have a second dopant level, which is greater than the region dopant level.02-03-2011

Patent applications by Christopher E. Dubé, Lexington, MA US

George Dubé, Chesterfield, MO US

Patent application numberDescriptionPublished
20110235177ATHERMAL ABIREFRINGENT OPTICAL COMPONENTS - An optical device to reduce the thermally induced distortion and thermally induced depolarization of light transmitted through all or part of the device. The device includes a nominally transparent element having a negative dn/dT and a nominally transparent element having a zero or negative stress optic coefficient.09-29-2011

Marc Arnold DubÉ, Ottawa CA

Patent application numberDescriptionPublished
20080250700Apparatus and Method for Bio-Fuel Production - An apparatus for the production of a bio-fuel or a bio-fuel additive from plant-derived oils, animal fats or a mixture thereof, suitable for use in a diesel engine is disclosed. The apparatus comprises a porous membrane for separating a reaction mixture from a permeate, the reaction mixture comprising an alcohol, a feedstock comprising plant-derived oils, animal fats or mixture thereof, and a catalyst for converting said feedstock to a bio-fuel or a bio-fuel additive, wherein said porous membrane is substantially impermeable to the feedstock and substantially permeable to said bio-fuel or bio-fuel additive. A method using said porous membrane in the production of a bio-fuel or a bio-fuel additive is also disclosed10-16-2008
20100307051BIODIESEL PRODUCTION USING ULTRA LOW CATALYST CONCENTRATIONS IN A MEMBRANE REACTOR - A method for producing a fuel or fuel additive comprising providing a reaction mixture comprising oil and an alcohol in an oil-in-alcohol emulsion and a catalyst for converting the oil to the fuel or the fuel additive. The oil and the alcohol are reacted in the presence of the catalyst, at a concentration below that used in a conventional batch process, to produce the fuel or fuel additive. This low level of catalyst reduces the formation of diols and oxidation products that can diminish the quality of the fuel or fuel additive. The fuel or fuel additive produced is continuously removed during the reaction, effectively de-coupling the concentration of catalyst used from the rate of the two phase reaction.12-09-2010

Marc Arnold DubÉ, Ottawa CA

Patent application numberDescriptionPublished
20100307051BIODIESEL PRODUCTION USING ULTRA LOW CATALYST CONCENTRATIONS IN A MEMBRANE REACTOR - A method for producing a fuel or fuel additive comprising providing a reaction mixture comprising oil and an alcohol in an oil-in-alcohol emulsion and a catalyst for converting the oil to the fuel or the fuel additive. The oil and the alcohol are reacted in the presence of the catalyst, at a concentration below that used in a conventional batch process, to produce the fuel or fuel additive. This low level of catalyst reduces the formation of diols and oxidation products that can diminish the quality of the fuel or fuel additive. The fuel or fuel additive produced is continuously removed during the reaction, effectively de-coupling the concentration of catalyst used from the rate of the two phase reaction.12-09-2010

Marie-Pierre Dubé, Montreal CA

Patent application numberDescriptionPublished
20100304393Genetic predictors of international normalized ratio (INR) fluctuation with warfarin therapy - There are disclosed methods and kits for identifying a subject having genetic predictors of predisposition to abnormal international normalized ratio (INR) fluctuation during warfarin therapy. In an embodiment, a method includes testing the subject to check for a presence of a predetermined genetic variation. The predetermined genetic variation is correlated with abnormal INR fluctuation during warfarin therapy. The subject is identified as having a predisposition to abnormal INR fluctuation during warfarin therapy when the testing indicates the presence of the predetermined genetic variation. In one embodiment, a kit includes a test to check the subject for a presence of a predetermined genetic variation. The predetermined genetic variation is correlated with abnormal INR fluctuation during warfarin therapy. The kit includes an indicator to identify the presence of the predetermined genetic variation so as to identify the subject as having a predisposition to abnormal INR fluctuation during warfarin therapy.12-02-2010

Marie-Pierre Dubé, Montreal CA

Patent application numberDescriptionPublished
20100190161MUTATIONS IN HUMAN UBIAD1 - The invention relates to polynucleotides and polypeptides which encode UBIAD1.07-29-2010
20100304393Genetic predictors of international normalized ratio (INR) fluctuation with warfarin therapy - There are disclosed methods and kits for identifying a subject having genetic predictors of predisposition to abnormal international normalized ratio (INR) fluctuation during warfarin therapy. In an embodiment, a method includes testing the subject to check for a presence of a predetermined genetic variation. The predetermined genetic variation is correlated with abnormal INR fluctuation during warfarin therapy. The subject is identified as having a predisposition to abnormal INR fluctuation during warfarin therapy when the testing indicates the presence of the predetermined genetic variation. In one embodiment, a kit includes a test to check the subject for a presence of a predetermined genetic variation. The predetermined genetic variation is correlated with abnormal INR fluctuation during warfarin therapy. The kit includes an indicator to identify the presence of the predetermined genetic variation so as to identify the subject as having a predisposition to abnormal INR fluctuation during warfarin therapy.12-02-2010

Patent applications by Marie-Pierre Dubé, Montreal CA

Serge Dubé, Montreal CA

Patent application numberDescriptionPublished
20120055182CO2 REFRIGERATION SYSTEM03-08-2012

Susan DubÉ, Carlsbad, CA US

Patent application numberDescriptionPublished
20110166215METHODS OF IMPROVING THE PHARMACOKINETICS OF DOXEPIN - Methods of improving the pharmacokinetics of doxepin in a patient.07-07-2011

Susan E. Dubé, Carlsbad, CA US

Patent application numberDescriptionPublished
20100179214DOXEPIN TRANS ISOMERS AND ISOMERIC MIXTURES AND METHODS OF USING THE SAME TO TREAT SLEEP DISORDERS - The invention relates to use of the trans-(E) isomer or isomeric mixtures containing specified ratios of the trans-(E) and cis-(Z) isomers of doxepin, metabolites of doxepin, pharmaceutically-acceptable salts of doxepin and prodrugs of the same; compositions containing the same, for the treatment of sleep disorders07-15-2010
20100179215DOXEPIN ISOMERS AND ISOMERIC MIXTURES AND METHODS OF USING THE SAME TO TREAT SLEEP DISORDERS - The invention relates to use of the cis-(Z) isomer or isomeric mixtures containing specified ratios of the cis-(Z) and trans-(E) isomers of doxepin, metabolites of doxepin, pharmaceutically-acceptable salts of doxepin and prodrugs of the same; compositions containing the same, for the treatment of sleep disorders07-15-2010

Sylvain Dubé, Boras SE

Patent application numberDescriptionPublished
20100115830SYSTEM FOR MODULATING PLANT GROWTH OR ATTRIBUTES05-13-2010

Sylvain Dubé, Boras SE

Patent application numberDescriptionPublished
20100115830SYSTEM FOR MODULATING PLANT GROWTH OR ATTRIBUTES05-13-2010

Yannick Dubé, Fermont CA

Patent application numberDescriptionPublished
20110239494DIPPER DOOR RETARDING MECHANISM - A retarding mechanism for continuously retarding the swinging movements of a dipper door is disclosed. The retarding mechanism comprises a hydraulic braking assembly mounted to the dipper bucket and operatively connected to the dipper door via at least one braking arm pivotally mounted within the braking assembly and at least one linking member pivotally mounted to the dipper door. The retarding mechanism continuously retards the opening and closing movements of the dipper door by controllably braking or slowing the at least one braking arm using the compressive action of at least one hydraulic piston mounted to the braking assembly.10-06-2011